Soz, to be clearer, by saying progression to FDA, I took it to mean Australian data confidence intervals were unnecessary for the company to progress towards FDA (ie to launch US studies)
Conference Call Summary, page-233
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #